In the early 1990s, a pivotal randomised trial sponsored by the National Institute of Neurological Disorders and Stroke ...

the absolute excess risk of stroke in patients older than age 75 years receiving thrombolytic treatment was <1%, and there was no age-associated excess in the risk of other major bleeding ...

It has now been 25 years since prourokinase was in the spotlight as a potential treatment for acute ischaemic stroke. In 1999, the PROACT-II randomised controlled trial compared intra-arterial ...

In total, two hundred and thirty-five patients were diagnosed with ischemic stroke, of which eighty-two patients received thrombolytic treatment. Ultimately, eighty-eight interviews were conducted ...

Contemporary thrombolytics in acute ischemic stroke are limited to administration within 4.5 hours of last known ... These findings suggest that JX10 may have a tolerable safety profile as a ...

Fast response is vital Although advances have been made in the treatment of stroke including thrombolytic drugs such as Alteplase they have a modest window of utilisation and are known to cause ...

Indian registry confirms mechanical thrombectomy for stroke is cost-effective, with excellent outcomes, but underutilized due ...

therapy after acute ischaemic stroke (AIS) is essential. We aimed to investigate the safety and effectiveness of EA therapy in patients who had an AIS with haemorrhagic infarction (HI) after ...

EXCLUSIVE - New data gives a worrying insight into how stroke patients are treated on arrival at hospital, as charity tells ...

In pediatric stroke, advancements have been made in diagnosis, treatment, and outcomes; however, existing gaps still need to be addressed.